Myelodysplastic syndromes: the complexity of stem-cell diseases

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Increasing prevalence of myelodysplastic syndromes (MDS) due to aging populations and improved diagnostics.
• MDS encompasses diverse conditions sharing clinical features, not a single entity.
• A significant characteristic of MDS is genetic instability, often progressing to acute myeloid leukaemia (AML).

Purpose of the Study:

• To review emerging principles in myelodysplastic syndromes (MDS) biology.
• To explore the overlap between MDS and acute myeloid leukaemia (AML) at the stem-cell level.
• To discuss genetic instability, apoptosis deregulation, and treatment-related MDS/AML.

Main Methods:

• Literature review of emerging principles in MDS biology.
• Synthesis of current understanding of MDS pathogenesis.
• Focus on stem-cell dysfunction, genetic instability, and apoptosis deregulation.

Main Results:

• Identified three key emerging principles in MDS biology.
• Highlighted the overlap between MDS stem-cell dysfunction and AML.
• Discussed the role of genetic instability and apoptosis deregulation in MDS progression.

Conclusions:

• Understanding MDS biology is crucial due to increasing prevalence and progression to AML.
• Emerging principles offer insights into MDS pathogenesis and potential therapeutic targets.
• Further research into stem-cell dysfunction, genetic instability, and apoptosis is warranted.